Home The Word Brain My Amedeo FAQ Privacy About   


C49

In our changing world, speaking just English isn't enough. Open new doors with skills in another world language.

Start with 7 words a day.

Next week: +49.


  Pancreatitis

  Free Subscription


Articles published in Ann Surg

Retrieve available abstracts of 111 articles:
HTML format



Single Articles


    April 2025
  1. UNNO M, Motoi F, Matsuyama Y, Satoi S, et al
    Neoadjuvant Chemotherapy with Gemcitabine and S-1 versus Upfront Surgery for Resectable Pancreatic Cancer: Results of the Randomized Phase II/III Prep-02/JSAP05 Trial.
    Ann Surg. 2025 Apr 16. doi: 10.1097/SLA.0000000000006730.
    PubMed     Abstract available


  2. GARNIER J, Marchetti A, Campbell B, Andel PCM, et al
    Carbohydrate Antigen 19-9 Delta Function for Survival Prediction in Borderline Pancreatic Cancer. A PANC-PALS Consortium International Multicenter Derivation and Validation Study.
    Ann Surg. 2025 Apr 16. doi: 10.1097/SLA.0000000000006735.
    PubMed     Abstract available


  3. QIAO G, Li X, Mohamed M, Bolm L, et al
    Efficacy of Neoadjuvant Therapy and the Prognostic Significance of Serum Carcinoembryonic Antigen Level in Patients with Localized Pancreatic Adenocarcinoma with Non-elevated Carbohydrate Antigen 19-9 Levels.
    Ann Surg. 2025 Apr 8. doi: 10.1097/SLA.0000000000006719.
    PubMed     Abstract available


  4. KONE LB, Perez-Iglesias CT, Banulescu M, Maker VK, et al
    Perioperative Broad-spectrum Antibiotics are Associated With Decreased Surgical Site Infections Compared to 1st-3rd Generation Cephalosporins After Open Pancreaticoduodenectomy in Patients With Jaundice or a Biliary Stent: Erratum.
    Ann Surg. 2025;281:e5.
    PubMed    


    March 2025
  5. PFLUGER MJ, Zucha DM, Kinny-Koster B, Pedro BA, et al
    Ductal Cancerization at the Pancreatic Neck Margin: Prevalence and Oncologic Relevance.
    Ann Surg. 2025 Mar 27. doi: 10.1097/SLA.0000000000006706.
    PubMed     Abstract available


  6. LEWELLEN KA, Maatman TK, Thyen AJ, Lark ME, et al
    Contemporary Outcomes of Pancreatic Head Resection for Chronic Pancreatitis.
    Ann Surg. 2025 Mar 21. doi: 10.1097/SLA.0000000000006700.
    PubMed     Abstract available


  7. ISHIDA H, Franklin O, Franco SR, Clark TJ, et al
    Surgery for Borderline Resectable and Locally Advanced Pancreatic Cancer with Arterial Encasement after Neoadjuvant Therapy: A Single-center Experience.
    Ann Surg. 2025 Mar 6. doi: 10.1097/SLA.0000000000006690.
    PubMed     Abstract available


  8. HABIB JR, Rompen IF, Javed AA, Campbell BA, et al
    Neoadjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasm-derived Pancreatic Cancer.
    Ann Surg. 2025 Mar 5. doi: 10.1097/SLA.0000000000006687.
    PubMed     Abstract available


  9. BARRETO SG, Strobel O, Salvia R, Marchegiani G, et al
    Complexity and Experience Grading to Guide Patient Selection for Minimally Invasive Pancreatoduodenectomy: An International Study Group for Pancreatic Surgery (ISGPS) Consensus.
    Ann Surg. 2025;281:417-429.
    PubMed     Abstract available


    February 2025
  10. LIU C, Cheng H, Wang M, Cai Y, et al
    Effect of Laparoscopic versus Open Distal Pancreatectomy on Recurrence-Free Survival in Patients with Left-sided Pancreatic Cancer: A randomized controlled trial.
    Ann Surg. 2025 Feb 25. doi: 10.1097/SLA.0000000000006681.
    PubMed     Abstract available


  11. HECKLER M, Abdallah S, Kinny-Koster B, Berchtold C, et al
    Temporary Portal Vein Bypass for Resection of Pancreatic Neoplasms.
    Ann Surg. 2025 Feb 10. doi: 10.1097/SLA.0000000000006662.
    PubMed     Abstract available


  12. JAVED AA, Habib JR, Andel PCM, Campbell BA, et al
    Implications of Neoadjuvant Therapy on Prognostic Factors in Pancreatic Ductal Adenocarcinoma: A Path Towards Personalized Prognostication.
    Ann Surg. 2025 Feb 7. doi: 10.1097/SLA.0000000000006660.
    PubMed     Abstract available


  13. NZENWA IC, Panossian VS, DeWane MP, Albutt KH, et al
    Volume Matters: Examining The Management Of Necrotizing Pancreatitis In The United States.
    Ann Surg. 2025 Feb 4. doi: 10.1097/SLA.0000000000006649.
    PubMed     Abstract available


  14. YACHIDA S, Yoshinaga S, Shiba S, Urabe M, et al
    KRAS Mutations in Duodenal Lavage Fluid after Secretin Stimulation for Detection of Pancreatic Cancer.
    Ann Surg. 2025 Feb 4. doi: 10.1097/SLA.0000000000006645.
    PubMed     Abstract available


    January 2025
  15. ROMPEN IF, Stoop TF, van Roessel S, van Veldhuisen E, et al
    Validation of the PANAMA-Score for Survival and Benefit of Adjuvant Therapy in Patients with Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX.
    Ann Surg. 2025 Jan 31. doi: 10.1097/SLA.0000000000006650.
    PubMed     Abstract available


  16. MONTORSI RM, Strijbos BTM, Stommel MWJ, van Laarhoven K, et al
    Preventing and Treating Delayed Gastric Emptying (DGE) after Pancreatic Surgery: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Ann Surg. 2025 Jan 29. doi: 10.1097/SLA.0000000000006642.
    PubMed     Abstract available


  17. STOOP TF, Molnar A, Seelen LWF, Sugawara T, et al
    Tangential Versus Segmental Portomesenteric Venous Resection During Pancreatoduodenectomy for Pancreatic Cancer: An International Multicenter Cohort Study on Surgical and Oncological Outcome.
    Ann Surg. 2025 Jan 22. doi: 10.1097/SLA.0000000000006638.
    PubMed     Abstract available


  18. PITAKTEERABUNDIT T, Fagenholz PJ, Luckhurst CM, Srinivas Rao S, et al
    Pancreatic Fistula and Intraabdominal Fluid Collections after Distal Pancreatectomy: Incidence, Implications, and Natural History.
    Ann Surg. 2025 Jan 20. doi: 10.1097/SLA.0000000000006635.
    PubMed     Abstract available


  19. VENTIN M, Arya S, Cattaneo G, Fernandez-Del Castillo C, et al
    Clinicopathological Characteristics and Long-Term Outcomes of Cystic vs. Solid Pancreatic Neuroendocrine Tumors: A Multi-Institutional Experience with 1727 Patients.
    Ann Surg. 2025 Jan 9. doi: 10.1097/SLA.0000000000006624.
    PubMed     Abstract available



  20. Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical Trial.
    Ann Surg. 2025;281:e1.
    PubMed    


    December 2024
  21. HUANG L, Han Q, Zhao L, Wang Z, et al
    Development and Validation of the Predictive and Prognostic ChemoResist Signature in Resected Pancreatic Ductal Adenocarcinoma: Multicenter Study.
    Ann Surg. 2024 Dec 16. doi: 10.1097/SLA.0000000000006610.
    PubMed     Abstract available


  22. ISHIDA H, Watanabe S, Rodriguez Franco S, Franklin O, et al
    Portomesenteric Venous Thrombosis after Pancreatic Cancer Surgery with Venous Resection and Reconstruction: Timing, Incidence, and Risk Factors.
    Ann Surg. 2024 Dec 16. doi: 10.1097/SLA.0000000000006605.
    PubMed     Abstract available


  23. AHMAD MU, Javadi CS, Chang JD, Forgo E, et al
    Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which is Best?
    Ann Surg. 2024 Dec 16. doi: 10.1097/SLA.0000000000006609.
    PubMed     Abstract available


  24. QIAO G, Bai X, Li X, Zhang Q, et al
    Systemic Treatment Followed by Radical Resection Combined with Intestinal Autotransplantation (RRCIA) for Locally Advanced Pancreatic Cancer: A Retrospectively Observational and Prospectively Validated Study.
    Ann Surg. 2024 Dec 11. doi: 10.1097/SLA.0000000000006600.
    PubMed     Abstract available


  25. LI H, Ma T, Lin WC, Lao M, et al
    Risk Factors, Manifestations, and Implications of Chyle Leak -Following Pancreatic Surgery: The Volume May Outweigh the Milky Appearance of the Drainage in a Chyle Leak.
    Ann Surg. 2024 Dec 11. doi: 10.1097/SLA.0000000000006599.
    PubMed     Abstract available


    November 2024
  26. KINNY-KOSTER B, Lambrecht A, Flossmann V, Steinle V, et al
    Alloplastic Vascular Grafts for Venous Interposition in Pancreatic Surgery: Readily Available and Reliable.
    Ann Surg. 2024 Nov 7. doi: 10.1097/SLA.0000000000006581.
    PubMed     Abstract available


  27. VILLASANTE S, Fernandes N, Perez M, Cordobes MA, et al
    Prediction of Severe Acute Pancreatitis at a Very Early Stage of the Disease Using Artificial Intelligence Techniques, Without Laboratory Data or Imaging Tests: The PANCREATIA Study.
    Ann Surg. 2024 Nov 5. doi: 10.1097/SLA.0000000000006579.
    PubMed     Abstract available


  28. HENDRIKS TE, Balduzzi A, van Dieren S, Suurmeijer JA, et al
    Interobserver Variability in the International Study Group for Pancreatic Surgery (ISGPS)-Defined Complications After Pancreatoduodenectomy: An International Cross-Sectional Multicenter Study.
    Ann Surg. 2024;280:728-733.
    PubMed     Abstract available


    October 2024
  29. MCGUIGAN MC, Hadjicosti R, Cameron AJ, Coats M, et al
    The Surveillance Strategy for Intraductal Pancreatic Mucinous Neoplasms: Criteria for Discontinuation.
    Ann Surg. 2024 Oct 31. doi: 10.1097/SLA.0000000000006580.
    PubMed     Abstract available


  30. BANNONE E, Cattelani A, Corvino G, Marchetti A, et al
    Clinical and Financial Validation of the International Study Group for Pancreatic Surgery (ISGPS) Definition of Post-Pancreatectomy Acute Pancreatitis (PPAP): International Multicenter Prospective Study.
    Ann Surg. 2024 Oct 22. doi: 10.1097/SLA.0000000000006569.
    PubMed     Abstract available


  31. LIONETTO G, Mattiolo P, Ciulla C, Savegnago G, et al
    Morphologic Characterization of Pancreatic Ductal Adenocarcinoma following Post-neoadjuvant Pancreatectomy and Clinical value of Intratumor Heterogeneity.
    Ann Surg. 2024 Oct 15. doi: 10.1097/SLA.0000000000006565.
    PubMed     Abstract available


  32. VITELLO DJ, Shah D, Wells A, Masnyk L, et al
    Mutant KRAS in Circulating Tumor DNA as a Biomarker in Localized Pancreatic Cancer in Patients Treated with Neoadjuvant Chemotherapy.
    Ann Surg. 2024 Oct 14. doi: 10.1097/SLA.0000000000006562.
    PubMed     Abstract available


    September 2024
  33. ROMPEN IF, Habib JR, Kinny-Koster B, Campbell BA, et al
    Total versus Partial Pancreatectomy in Patients with Pancreatic Cancer Arising from Multifocal or Diffuse Intraductal Papillary Mucinous Neoplasia - A Multicenter Observational Study.
    Ann Surg. 2024 Sep 18. doi: 10.1097/SLA.0000000000006538.
    PubMed     Abstract available


  34. JAVED AA, Rompen IF, van Goor IWJM, Stoop TF, et al
    Poor Prognostic Factors in Long-Term Survivors of Resected Pancreatic Ductal Adenocarcinoma: An International, Multicenter Cohort Study.
    Ann Surg. 2024 Sep 17. doi: 10.1097/SLA.0000000000006539.
    PubMed     Abstract available


  35. NICOLSON NG, Tandurella JA, Wu LW, Patel J, et al
    Patient-derived Organoid Pharmacotyping As A Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2024 Sep 4. doi: 10.1097/SLA.0000000000006517.
    PubMed     Abstract available


  36. KIM RC, Perri G, Rocha Castellanos DM, Jung H, et al
    Natural History of the Remnant Pancreatic Duct after Pancreatoduodenectomy for Non-Invasive Intraductal Papillary Mucinous Neoplasm: Results from an International Consortium.
    Ann Surg. 2024 Sep 3. doi: 10.1097/SLA.0000000000006519.
    PubMed     Abstract available


  37. HARRISON JM, Day H, Arnow K, Ngongoni RF, et al
    What's Behind it all: A Retrospective Cohort Study of Retrogastric Pancreatic Necrosis Management.
    Ann Surg. 2024 Sep 3. doi: 10.1097/SLA.0000000000006521.
    PubMed     Abstract available


    August 2024
  38. WANG J, Ashraf Ganjouei A, Romero-Hernandez F, Foroutani L, et al
    A Computer Vision Algorithm to Predict Superior Mesenteric Artery Margin Status for Patients with Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2024 Aug 23. doi: 10.1097/SLA.0000000000006506.
    PubMed     Abstract available


  39. KAPOOR D, Desiraju Y, Chaudhari VA, Bagwan AI, et al
    Validation and Optimisation of the ISGPS Risk Classification for Postoperative Pancreatic Fistula after Pancreatoduodenectomy for Periampullary Tumours.
    Ann Surg. 2024 Aug 13. doi: 10.1097/SLA.0000000000006485.
    PubMed     Abstract available


  40. SCHUH F, Yildirim B, Klotz R, Pianka F, et al
    Prospective Validation of the Pancreatic Fistula Risk Classification by the International Study Group for Pancreatic Surgery (PARIS trial).
    Ann Surg. 2024 Aug 8. doi: 10.1097/SLA.0000000000006481.
    PubMed     Abstract available


  41. PINSON J, Henriques J, Beaussire L, Sarafan-Vasseur N, et al
    New Biomarkers to Define A Biological Borderline Situation for Pancreatic Adenocarcinoma - Results of An Ancillary Study of the PANACHE01-PRODIGE48 Trial.
    Ann Surg. 2024 Aug 5. doi: 10.1097/SLA.0000000000006468.
    PubMed     Abstract available


    July 2024
  42. LAMBERT A, Salleron J, Harle A, Biagi JJ, et al
    Impact of Positive Resection Margins on Recurrence and Survival Following Resection and Adjuvant Chemotherapy in Pancreatic Cancer: Results of the PRODIGE 24-CCTG PA-6 Randomized Controlled Trial.
    Ann Surg. 2024 Jul 23. doi: 10.1097/SLA.0000000000006449.
    PubMed     Abstract available


  43. SUZUKI S, Omori Y, Ono Y, Hirose K, et al
    Three Molecular Developmental Pathways of Remnant Pancreatic Cancer after Resection: A Nationwide Project Study of Japan Pancreas Society.
    Ann Surg. 2024 Jul 17. doi: 10.1097/SLA.0000000000006444.
    PubMed     Abstract available


  44. SERVIN-ROJAS M, Fong ZV, Fernandez-Del Castillo C, Lionetto G, et al
    Lymph Node Yield is Associated with Improved Overall Survival and Increased Time to Recurrence in Node-Negative Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy.
    Ann Surg. 2024 Jul 2. doi: 10.1097/SLA.0000000000006432.
    PubMed     Abstract available


    June 2024
  45. MAGNIN J, Jolissaint JS, Fuchs HE, Seier K, et al
    Safety of Selective Operative Drainage After Pancreatic Resection: A Retrospective Analysis of 2,607 Patients.
    Ann Surg. 2024 Jun 28. doi: 10.1097/SLA.0000000000006425.
    PubMed     Abstract available


  46. KLOTZ R, Hank T, Berente MP, Joos M, et al
    Preoperative Surgical or Endoscopic Bile Duct Drainage in Pancreatic Cancer.
    Ann Surg. 2024 Jun 21. doi: 10.1097/SLA.0000000000006407.
    PubMed     Abstract available


  47. LEE JJ, Kearney JF, Trembath HE, Hariharan A, et al
    Tumor-intrinsic and Cancer-associated Fibroblast Subtypes Independently Predict Outcomes in Pancreatic Cancer.
    Ann Surg. 2024 Jun 18. doi: 10.1097/SLA.0000000000006416.
    PubMed     Abstract available


  48. WEHRLE CJ, Hossain MS, Perlmutter B, Chang JH, et al
    Consequences of a Surveillance Strategy for Side-Branch Intraductal Pancreatic Mucinous Neoplasms: Long-Term Follow-Up of One-Thousand Cysts.
    Ann Surg. 2024 Jun 6. doi: 10.1097/SLA.0000000000006383.
    PubMed     Abstract available


    May 2024
  49. KASLOW SR, Sharma AR, Hewitt DB, Bridges JFP, et al
    Quantifying Patient Risk Threshold in Managing Pancreatic Intraductal Papillary Mucinous Neoplasms.
    Ann Surg. 2024 May 29. doi: 10.1097/SLA.0000000000006357.
    PubMed     Abstract available


  50. KHALILIEH S, Iyer A, Hammelef E, Zohar N, et al
    Major Pancreatic Resection Increases Bone Mineral Density Loss, Osteoporosis, and Fractures.
    Ann Surg. 2024 May 22. doi: 10.1097/SLA.0000000000006326.
    PubMed     Abstract available


  51. YONKUS JA, Alva-Ruiz R, Colglazier JJ, Kendrick ML, et al
    Outcomes of Visceral Arterial Interposition Graft Reconstruction for Locally Advanced Pancreatic Cancer.
    Ann Surg. 2024 May 21. doi: 10.1097/SLA.0000000000006350.
    PubMed     Abstract available


  52. KE L, Ye B, Huang M, Chen T, et al
    Balanced Solution versus Normal Saline in Predicted Severe Acute Pancreatitis: A Stepped Wedge Cluster Randomized Trial.
    Ann Surg. 2024 May 6. doi: 10.1097/SLA.0000000000006319.
    PubMed     Abstract available


  53. SCHOUTEN TJ, Kroon VJ, Besselink MG, Bosscha K, et al
    Perineural Invasion is an Important Prognostic Factor in Patients With Radically Resected (R0) and Node-negative (pN0) Pancreatic Cancer.
    Ann Surg. 2024 May 6. doi: 10.1097/SLA.0000000000006320.
    PubMed     Abstract available


  54. MALLEO G, Lionetto G, Crippa S, Qadan M, et al
    Reappraising the Role of Intraoperative Neck Margin Revision in Post-Neoadjuvant Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis.
    Ann Surg. 2024 May 6. doi: 10.1097/SLA.0000000000006322.
    PubMed     Abstract available


  55. JAMES P, Kaushal D, Beaumont Wilson R
    NETosis in Surgery: Pathophysiology, Prevention, and Treatment.
    Ann Surg. 2024;279:765-780.
    PubMed     Abstract available


    April 2024
  56. GAUJOUX S, Regimbeau JM, Piessen G, Truant S, et al
    Somatostatin vs. Octreotide for Prevention of Postoperative Pancreatic Fistula The PREFIPS Randomized Clinical Trial A FRENCH 007 - ACHBT Study.
    Ann Surg. 2024 Apr 25. doi: 10.1097/SLA.0000000000006313.
    PubMed     Abstract available


  57. ECKHOFF AM, Fletcher AA, Kelly MS, Dohlman A, et al
    Comprehensive Assessment of the Intrinsic Pancreatic Microbiome.
    Ann Surg. 2024 Apr 16. doi: 10.1097/SLA.0000000000006299.
    PubMed     Abstract available


  58. HABIB JR, Rompen IF, Kaslow SR, Grewal M, et al
    Defining the Minimal and Optimal Thresholds for Lymph Node Resection and Examination for Intraductal Papillary Mucinous Neoplasm Derived Pancreatic Cancer: A Multicenter Retrospective Analysis.
    Ann Surg. 2024 Apr 12. doi: 10.1097/SLA.0000000000006295.
    PubMed     Abstract available


  59. BRADA LJH, Schouten TJ, Daamen LA, Seelen LWF, et al
    Evaluation of Short- and Long-Term Outcomes After Resection in Patients with Locally Advanced versus (Borderline) Resectable Pancreatic Cancer.
    Ann Surg. 2024 Apr 1. doi: 10.1097/SLA.0000000000006289.
    PubMed     Abstract available


    March 2024
  60. LUCOCQ J, Halle-Smith J, Haugk B, Joseph N, et al
    Long-term Outcomes following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) versus Pancreatic Ductal Adenocarcinoma (PDAC): A Propensity-score Matched Analysis.
    Ann Surg. 2024 Mar 22. doi: 10.1097/SLA.0000000000006272.
    PubMed     Abstract available


  61. CASS SH, Tzeng CD, Prakash LR, Maxwell J, et al
    Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic Cancer.
    Ann Surg. 2024 Mar 20. doi: 10.1097/SLA.0000000000006269.
    PubMed     Abstract available


  62. CHEN H, Wang W, Fu N, Xia W, et al
    Characterization of Pancreatic Fistula after Post-pancreatectomy Acute Pancreatitis.
    Ann Surg. 2024 Mar 19. doi: 10.1097/SLA.0000000000006277.
    PubMed     Abstract available


    February 2024
  63. BOGGI U, Kauffmann E, Napoli N, Barreto SG, et al
    REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer.
    Ann Surg. 2024 Feb 26. doi: 10.1097/SLA.0000000000006248.
    PubMed     Abstract available


  64. CHEN H, Wang Y, Jiang K, Xu Z, et al
    The Effect of Perioperative Dexamethasone on Postoperative Complications after Pancreaticoduodenectomy: A Multicenter Randomized Controlled Trial.
    Ann Surg. 2024 Feb 22. doi: 10.1097/SLA.0000000000006240.
    PubMed     Abstract available


  65. LI L, Zhang Q, Feng Y, Kong F, et al
    A Novel Serum Exosomal miRNA Signature in the Early Prediction of Persistent Organ Failure in Patients with Acute Pancreatitis.
    Ann Surg. 2024 Feb 7. doi: 10.1097/SLA.0000000000006229.
    PubMed     Abstract available


  66. PERRI G, Romandini E, Marchegiani G, Ghorbani P, et al
    Postoperative Hyperamylasemia (POH) is an Early Predictor of Pancreatic Fistula Occurrence and Severity after Distal Pancreatectomy: Results from a European Multicentric Study.
    Ann Surg. 2024 Feb 2. doi: 10.1097/SLA.0000000000006222.
    PubMed     Abstract available


    January 2024
  67. STEIN-THOERINGER CK, Renz BW, De Castilhos J, von Ehrlich-Treuenstatt V, et al
    Microbiome Dysbiosis with Enterococcus Presence in the Upper Gastrointestinal Tract is A Risk Factor for Mortality in Patients Undergoing Surgery for Pancreatic Cancer.
    Ann Surg. 2024 Jan 26. doi: 10.1097/SLA.0000000000006210.
    PubMed     Abstract available


  68. OU H, Chen M, Qin K, Zhao S, et al
    Short-term and Long-term Outcomes of Robotic Enucleation of Tumors Located in the Pancreatic Head and Uncinate Process.
    Ann Surg. 2024 Jan 23. doi: 10.1097/SLA.0000000000006198.
    PubMed     Abstract available


  69. SHAH D, Wells A, Cox M, Dawravoo K, et al
    Prospective Evaluation of Circulating Tumor DNA using Next Generation Sequencing as a Biomarker during Neoadjuvant Chemotherapy in Localized Pancreatic Cancer.
    Ann Surg. 2024 Jan 23. doi: 10.1097/SLA.0000000000006209.
    PubMed     Abstract available


  70. KOTECHA K, Tree K, Ziaziaris WA, McKay SC, et al
    Centralization of Pancreaticoduodenectomy: A Systematic Review and Spline Regression Analysis to Recommend Minimum Volume for a Specialist Pancreas Service.
    Ann Surg. 2024 Jan 23. doi: 10.1097/SLA.0000000000006208.
    PubMed     Abstract available


  71. ASSAWASIRISIN C, Qadan M, Aimprasittichai S, Kambadakone A, et al
    Pancreatic Serous Cystadenoma: A Continuing Diagnostic Challenge.
    Ann Surg. 2024 Jan 17. doi: 10.1097/SLA.0000000000006203.
    PubMed    


  72. NICKEL F, Kuemmerli C, Muller PC, Schmidt MW, et al
    The PAncreatic Surgery Composite Endpoint PACE - Development and Validation of a Clinically Relevant Endpoint Requiring Lower Sample Sizes.
    Ann Surg. 2024 Jan 12. doi: 10.1097/SLA.0000000000006194.
    PubMed     Abstract available


  73. MALLEO G, Casciani F, Lionetto G, Esposito A, et al
    Resection to Exploration Ratios and Associated Outcomes in Patients with Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2024 Jan 12. doi: 10.1097/SLA.0000000000006197.
    PubMed     Abstract available


    December 2023
  74. VAN VELDHUISEN CL, Leseman CA, De Rijk FEM, Dekker EN, et al
    Nationwide Outcome of Tailored Surgery for Symptomatic Chronic Pancreatitis based on Pancreatic Morphology: Validation of the International guidelines.
    Ann Surg. 2023 Dec 13. doi: 10.1097/SLA.0000000000006176.
    PubMed     Abstract available


  75. THEIJSE RT, Stoop TF, Hendriks TE, Suurmeijer JA, et al
    Nationwide Outcome after Pancreatoduodenectomy in Patients at very High Risk (ISGPS-D) for Postoperative Pancreatic Fistula.
    Ann Surg. 2023 Dec 11. doi: 10.1097/SLA.0000000000006174.
    PubMed     Abstract available


  76. ZHU X, Xiao Z, Liu H, Zhang P, et al
    Pancreatic Cancer: An Exocrine Tumor with Endocrine Characteristics.
    Ann Surg. 2023 Dec 5. doi: 10.1097/SLA.0000000000006168.
    PubMed     Abstract available


  77. CRIPPA S, Malleo G, Langella S, Ricci C, et al
    Cure Probabilities After Resection Of Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis Of 2554 Patients.
    Ann Surg. 2023 Dec 4. doi: 10.1097/SLA.0000000000006166.
    PubMed     Abstract available


  78. PERRI G, Marchegiani G, Partelli S, Andreasi V, et al
    Either High or Low Risk: The Acinar Score at the Resection Margin Dichotomizes the Risk Spectrum of Pancreas-specific Complications After Pancreatoduodenectomy.
    Ann Surg. 2023;278:e1242-e1249.
    PubMed     Abstract available


    November 2023
  79. QIN T, Zhang H, Pan S, Liu J, et al
    Effect of Laparoscopic and Open Pancreatoduodenectomy for Pancreatic or Periampullary Tumors: Three-year Follow-up of a Randomized Clinical Trial.
    Ann Surg. 2023 Nov 15. doi: 10.1097/SLA.0000000000006149.
    PubMed     Abstract available


  80. VERMA A, Balian J, Hadaya J, Premji A, et al
    Machine Learning Based Prediction of Postoperative Pancreatic Fistula Following Pancreaticoduodenectomy.
    Ann Surg. 2023 Nov 10. doi: 10.1097/SLA.0000000000006123.
    PubMed     Abstract available


  81. PULVIRENTI A, Javed AA, Michelakos T, Sekigami Y, et al
    Recurring Pancreatic Neuroendocrine Tumor: Timing and Pattern of Recurrence and Current Treatment.
    Ann Surg. 2023;278:e1063-e1067.
    PubMed     Abstract available


    October 2023
  82. ROMPEN IF, Levine J, Habib JR, Sereni E, et al
    Progression of Site-Specific Recurrence of Pancreatic Cancer and Implications for Treatment.
    Ann Surg. 2023 Oct 23. doi: 10.1097/SLA.0000000000006142.
    PubMed     Abstract available


  83. FUCHS J, Loos M, Kinny-Koster B, Hackert T, et al
    Pancreatic Surgery in Children: Complex, Safe and Effective.
    Ann Surg. 2023 Oct 17. doi: 10.1097/SLA.0000000000006125.
    PubMed     Abstract available


  84. QIAO G, Fong ZV, Bolm L, Fernandez Del-Castillo C, et al
    Feasibility, Safety, and Efficacy of Aggressive Multimodal Management of Elderly Patients with Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2023 Oct 13. doi: 10.1097/SLA.0000000000006131.
    PubMed     Abstract available


    September 2023
  85. PAIELLA S, Secchettin E, Lionetto G, Archibugi L, et al
    Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence meta-analysis to Estimate the Rate of low-yield Surgery.
    Ann Surg. 2023 Sep 8. doi: 10.1097/SLA.0000000000006094.
    PubMed     Abstract available


    August 2023
  86. IMAMURA T, Ohgi K, Mori K, Ashida R, et al
    Surrogacy of Recurrence-free Survival for Overall Survival as an Endpoint of Clinical Trials of Perioperative Adjuvant Therapy in Hepatobiliary-pancreatic Cancers: A Retrospective Study and Meta-analysis.
    Ann Surg. 2023 Aug 28. doi: 10.1097/SLA.0000000000006084.
    PubMed     Abstract available


  87. VAN DONGEN JC, van Dam JL, Besselink MG, Bonsing BA, et al
    Fistula Risk Score for Auditing Pancreatoduodenectomy: The Auditing-FRS.
    Ann Surg. 2023;278:e272-e277.
    PubMed     Abstract available


    July 2023
  88. ZHANG C, Zironda A, Vierkant RA, Starlinger P, et al
    Quality of Life and Gastrointestinal Symptoms in Long-term Survivors of Pancreatic Cancer Following Pancreatoduodenectomy.
    Ann Surg. 2023 Jul 27. doi: 10.1097/SLA.0000000000006053.
    PubMed     Abstract available


  89. SEELEN LWF, Doppenberg D, Stoop TF, Nagelhout A, et al
    Minimum and Optimal CA19-9 Response After Two Months Induction Chemotherapy in Patients with Locally Advanced Pancreatic Cancer: A Nationwide Multicenter Study.
    Ann Surg. 2023 Jul 21. doi: 10.1097/SLA.0000000000006021.
    PubMed     Abstract available


  90. MARCINIAK C, Lenne X, Bruandet A, Hamroun A, et al
    Risk-Benefit Balance of Simultaneous Gastric Bypass or Sleeve Gastrectomy and Concomitant Cholecystectomy: A Comprehensive Nationwide Cohort of 289,627 Patients.
    Ann Surg. 2023 Jul 21. doi: 10.1097/SLA.0000000000006039.
    PubMed     Abstract available


  91. PECORELLI N, Guarneri G, Vallorani A, Limongi C, et al
    Validation of the PROMIS-29 Questionnaire as a Measure of Recovery after Pancreatic Surgery.
    Ann Surg. 2023 Jul 19. doi: 10.1097/SLA.0000000000006020.
    PubMed     Abstract available


  92. VAN GOOR IWJM, Schouten TJ, Verburg DN, Besselink MG, et al
    Predicting Long-term Disease-free Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Cohort Study.
    Ann Surg. 2023 Jul 17. doi: 10.1097/SLA.0000000000006004.
    PubMed     Abstract available


  93. VAN VELDHUISEN CL, Sissingh NJ, Boxhoorn L, van Dijk SM, et al
    Long-Term Outcome of Immediate Versus Postponed Intervention in Patients With Infected Necrotizing Pancreatitis (POINTER): Multicenter Randomized Trial.
    Ann Surg. 2023 Jul 17. doi: 10.1097/SLA.0000000000006001.
    PubMed     Abstract available


  94. PODDA M, Di Martino M, Ielpo B, Catena F, et al
    The 2023 MANCTRA Acute Biliary Pancreatitis Care Bundle: A Joint Effort Between Human Knowledge and Artificial Intelligence (ChatGPT) to Optimize the Care of Patients With Acute Biliary Pancreatitis in Western Countries.
    Ann Surg. 2023 Jul 17. doi: 10.1097/SLA.0000000000006008.
    PubMed     Abstract available


  95. ABU HILAL M, van Ramshorst TME, Boggi U, Dokmak S, et al
    The Brescia Internationally Validated European Guidelines on Minimally Invasive Pancreatic Surgery (EGUMIPS).
    Ann Surg. 2023 Jul 14. doi: 10.1097/SLA.0000000000006006.
    PubMed     Abstract available


  96. VAN OOSTEN AF, Groot VP, Dorland G, Burkhart RA, et al
    Dynamics of Serum CA19-9 in Patients Undergoing Pancreatic Cancer Resection.
    Ann Surg. 2023 Jul 3. doi: 10.1097/SLA.0000000000005977.
    PubMed     Abstract available


  97. LOOS M, Konig AK, von Winkler N, Mehrabi A, et al
    Completion Pancreatectomy After Pancreatoduodenectomy: Who Needs It?
    Ann Surg. 2023;278:e87-e93.
    PubMed     Abstract available


    June 2023
  98. SNYDER RA, Dueck AC, Fruth B, Shi Q, et al
    Patient-Reported Adverse Events During Neoadjuvant Therapy in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501).
    Ann Surg. 2023 Jun 19. doi: 10.1097/SLA.0000000000005958.
    PubMed     Abstract available


  99. PULVIRENTI A, Hauser HF, Fiedler LM, McIntyre CA, et al
    Early-Onset Pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathology Features, and Oncological Outcomes.
    Ann Surg. 2023 Jun 16. doi: 10.1097/SLA.0000000000005941.
    PubMed     Abstract available


  100. ELLIS RJ, Brajcich BC, Bertens KA, Chan CHF, et al
    Association Between Biliary Pathogens, Surgical Site Infection, and Pancreatic Fistula: Results of a Randomized Trial of Perioperative Antibiotic Prophylaxis in Patients Undergoing Pancreatoduodenectomy.
    Ann Surg. 2023 Jun 14. doi: 10.1097/SLA.0000000000005955.
    PubMed     Abstract available


    May 2023
  101. SUGAWARA T, Rodriguez Franco S, Sherman S, Torphy RJ, et al
    Neoadjuvant Chemotherapy versus Upfront Surgery for Resectable Pancreatic Adenocarcinoma: An Updated Nationwide Study.
    Ann Surg. 2023 May 25. doi: 10.1097/SLA.0000000000005925.
    PubMed     Abstract available


  102. NIKIFOROVA MN, Wald AI, Spagnolo DM, Melan MA, et al
    A Combined DNA/RNA-based Next-Generation Sequencing Platform to Improve the Classification of Pancreatic Cysts and Early Detection of Pancreatic Cancer Arising from Pancreatic Cysts.
    Ann Surg. 2023 May 22. doi: 10.1097/SLA.0000000000005904.
    PubMed     Abstract available


  103. ARMSTRONG MT, Saadat LV, Chou JF, Gonen M, et al
    Risk Factors for Progression in Patients Undergoing Surveillance for Pancreatic Cysts.
    Ann Surg. 2023 May 22. doi: 10.1097/SLA.0000000000005922.
    PubMed     Abstract available


  104. STOOP TF, Bergquist E, Theijse RT, Hempel S, et al
    Systematic review and Meta-analysis of the Role of total Pancreatectomy as an Alternative to Pancreatoduodenectomy in Patients at High Risk for Postoperative Pancreatic Fistula: is it a Justifiable Indication?
    Ann Surg. 2023 May 9. doi: 10.1097/SLA.0000000000005895.
    PubMed     Abstract available


    April 2023
  105. THALJI SZ, Fernando D, Dua KS, Madhavan S, et al
    Biliary Adverse Events during Neoadjuvant Therapy for Pancreatic Cancer.
    Ann Surg. 2023 Apr 20. doi: 10.1097/SLA.0000000000005884.
    PubMed     Abstract available


  106. TAKAHASHI H, Akita H, Wada H, Miyata H, et al
    Pathological Nodal and Vascular Involvement Significantly Impacts the Recurrence Risk in Different Time Frames in Patients with Resectable and Borderline Resectable Pancreatic Cancer: Long-term Conditional Recurrence-free Survival Analysis in the Sett
    Ann Surg. 2023 Apr 14. doi: 10.1097/SLA.0000000000005879.
    PubMed     Abstract available


  107. ELSHAMI M, Ammoun AK, Mneimneh WS, Stitzel HJ, et al
    Discordance Between Conventional and Detailed Lymph Node Analysis in Resected, Node-negative Pancreatic or Ampullary Adenocarcinomas and Association with Adverse Survival Outcomes: A Single-institution Analysis.
    Ann Surg. 2023 Apr 13. doi: 10.1097/SLA.0000000000005870.
    PubMed     Abstract available


  108. LEONHARDT CS, Pils D, Qadan M, Jomrich G, et al
    The Revised R Status is an Independent Predictor of Postresection Survival in Pancreatic Cancer After Neoadjuvant Treatment.
    Ann Surg. 2023 Apr 12. doi: 10.1097/SLA.0000000000005874.
    PubMed     Abstract available


  109. NGO-HUANG AT, Parker NH, Xiao LC, Schadler KL, et al
    Effects of a Pragmatic Home-based Exercise Program Concurrent with Neoadjuvant Therapy on Physical Function of Patients with Pancreatic Cancer: The Pancfit Randomized Clinical Trial.
    Ann Surg. 2023 Apr 7. doi: 10.1097/SLA.0000000000005878.
    PubMed     Abstract available


  110. VAN 'T LAND FR, Aziz MH, Michiels N, Mieog JSD, et al
    Increasing Systemic Immune-Inflammation Index During Treatment in Patients with Advanced Pancreatic Cancer is Associated with Poor Survival - A Retrospective, Multicenter, Cohort Study.
    Ann Surg. 2023 Apr 3. doi: 10.1097/SLA.0000000000005865.
    PubMed     Abstract available


    March 2023
  111. LOOS M, Khajeh E, Mehrabi A, Kinny-Koster B, et al
    Distal Pancreatectomy with En-bloc Celiac Axis Resection (dp-car) for Locally Advanced Pancreatic Cancer: A Safe And Effective Procedure.
    Ann Surg. 2023 Mar 30. doi: 10.1097/SLA.0000000000005866.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pancreatitis is free of charge.